Fantasy Football - Footballguys Forums

Moonlight

Members
  • Content Count

    684
  • Joined

  • Last visited

Everything posted by Moonlight

  1. You guys are misled. This interview was from last year. The interview was done by Biotech Trader and they acknowledged that it is old. Explains why no mention of Covid. Not sure why it was dated as of this May. Interesting to me from the interview was that NP mentions the BLA submission for HIV would be finished in September, which would be September of last year. As we know it took more than a half year after September 2019 to accomplish that. It explains to me why the BLA submission was so critical to the company's and NP's credibility. Again fosters the sense that NP is overly optimistic about timelines Also NP talks about publication of a scientific article that would bolster their approach of txing HIV and increase public awareness of CYDY and leronlimab. Similar to where we are now re: Covid. As an investor I liked that he compared the company to Gilead. He mentioned that Gilead was basically present CYDY from 1992 to 1997 due to low public awareness, development and SP but then went on a roll. He believed that something similar was going to happen to CYDY in a year. Just seems to be so many positives in the future of the company. I'm in the process of freeing up additional cash to increase my holdings.
  2. Finished 'Valley Forge". Good basic revolutionary war non-fiction.
  3. Only 3 funny parts for me in TSAM ...frank & beans, mousse and dog attack scenes.
  4. If you need a question asked, I'll do what I can to ask it at the next cc.
  5. More Lions disrespect here https://www.yahoo.com/sports/reggie-wayne-refused-to-work-out-for-the-lions-when-he-was-a-free-agent-you-the-detroit-lions-182801380.html Wayne was a shell then. Lions viewed as cheap.
  6. Interesting thing that I didn't know, NP in the conference call said that Cytodyn had only 12 employees. That's a lot of ground to cover for everyone with all they have going.
  7. Funny. Biotechs were down for the day But I have mixed thoughts about this. Could also be attempt to discredit him.
  8. Seemed like a concerted attack on the stock today. I'm still in. So many positive developments on the horizon.
  9. Overview of where CYDY is at including information from yesterday's cc. https://biopharmajournal.com/2020/05/27/cytodyn-otcmktscydy-investor-update-unveils-coming-uplisting-and-potential-interim-readout-followed-by-a-massive-development-pipeline-plan/
  10. Did say they were hiring someone to specialize in commercialization of the product. Always waiting for results though is frustrating as everything seems to be in the "works". They have so much going on. If they submit their application for uplisting by the end of next week that would be cool.
  11. The optimism about opening up is very delusional to me. Some sensible Americans and companies are adapting to this new coronavirus world others are not. Virus is still there. Half of the states the virus is not contained. Once precautions are ignored and people become more complacent sure to spread dramatically again and business will suffer.
  12. Did say if they didn't have 75 in two weeks that he would seek board approval to go to FDA with interim results. Had the impression that there were more than 50 but less than 75 so far.
  13. CYDY Expect agreement with investment bank this weekend Expect exciting uplisting news next week
  14. Wonder if he's getting paid off by someone.
  15. Sounds like NYSE is going to be the route but nothing definite still working on it.
  16. Thanks to advice from this board I recently transferred my Roth IRA from to Fidelity specifically to avoid brokerage fees for CYDY trades. Received a call from Fidelity today regarding my CYDY stock. They advised that they needed info regarding where I had acquired CYDY. They stated that there was a problem in that Cytodyn was a shell company and that stock issued by Cytodyn directly to investors needed to be listed under the previous company's name and not the shell company. It sounded like there was a difference between CYDY and Fidelity regarding SEC requirements. Fidelity stated that there were millions of dollars of SEC fines involved. Also said that the clerk at Cytodyn had erroneously removed the name of the previous company as being the company of issuance. However, Fidelity said that this problem did not effect investors who had purchased shares through a brokerage but effected shares purchased directly from the company. I was asked to send my PNC documentation showing the purchase of my shares through PNC. Regarding the fines involved it sounded like Fidelity was at risk and not investors. Anyway thought you should be aware of this. Its my best understanding. Shorts may run with this.
  17. RE: CYDY when you have only scraps of information you are free to speculate and draw whatever conclusion fits your outlook, hope, fear or whatever is running you that day. The CC is being held at 4pm after exchange hours. A change from recent calls: is it significant? Or is it the time that was convenient for everybody to be present? Dr. Patterson apparently is not going to be on the call. What does that mean? Is he leaving the company? Had a prior commitment? Or wasn't needed? I think investors like myself are waiting for the spark that sets off the rocket and the waiting is hard. There is so much optimism on the boards and this usually makes me cautious but I find myself recommending the stock to family members which is atypical and therefore putting my neck out there. When I tell family members I learned about this pre-revenue stock from this guy on the football message board, I get the LOOK. But regardless, from what I have read about CYDY I believe in its future and the risk is worth the potential payoff. My only child died from cancer as did my mother and I wish the drug had been available as an option for them.
  18. Since its a Montefiore press release they might overemphasize their role but also very possible the PR person there didn't have a good understanding of the overall process.
  19. CYDY going to Mexico for exposure and validation is a way to counter this. Seems like an intelligent and assertive move. Additionally, Mexico may be in very bad shape and seeking alternative txs with more effective results.
  20. Thanks to you and McBokonon. Is there a charge to purchase? Excuse the questions. I've been a guy who has had almost all my money in equity index funds since I was younger. I did open a Roth for a short time when I didn't have a 401K. Just owned one stock Stryker but sold in anticipation of the virus led downturn. Used that money to purchase CYDY after reading about it here. I did invest in individual tocks when I was younger and got my ### handed to me in a hat.
  21. NP and the host are unpolished. You can do something about the host. As a recent investor I lack history with the company but on the surface it appears NP has been instrumental to bringing the company to where it is now. So I guess we take the bad with the good. I thought the webinar was informative regarding company thoughts and efforts. No huge booming news but the company seems to be advancing overall. Also going over the same information could be helpful to new potential investors tuning in.
  22. Requesting help regarding reducing my costs on CYDY trades. I have a Roth self trading account through PNC but they charge a real hefty commission because CYDY is on the pink sheets. I see that some of the guys here have day traded the stock and was wondering where you had your account as I assume you are avoiding some of these fees that are hurting me. Its becoming somewhat predictable that whenever NP speaks the stock goes down and I'd like to see if that is a tactic that could be used. Appreciate your thoughts and advice. Thanks
  23. An interesting aspect of the CYDY webinar was that NP mentioned that they were in talks with Mexico to participate in a study that would directly compare the effectiveness of leronlimab versus remdesivir. There would also be a direct comparison of the two separately versus a cocktail of leronlimab and remdesivir together. Also Dr. Patterson mentioned that other research is coming out now that shows the role of RANTES and will serve as broad based support for his paper and for the eventual use of leronlimab.
  24. Good news from CYDY webinar is that uplisting is in the works. They believe they meet the requirements and are in process of arranging the financial requirements with an agreement with an investment bank. Results from trials are good. Expect enrollment to be completed by end of May. Patterson article submitted and awaiting approval, need to address any comments or need for experimental data. Only thing of concern was that NP did not flat out reject further dilution to fund trials but said it was an option among others to be considered. Also Patterson again commented about the possibility of the virus in the nation's blood supply and the need to determine/test if present and if it was infectious. Again like before stock takes a hit during the webinar.